Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7334272

N/N=C\c1ccc2cc(C#CCNC(=O)c3ccc(N)cc3)ccc2c1.O=C(O)C(F)(F)F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOST Q9BQB4 1/20 0.38
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
HIF1A Q16665 1/20 0.34
SLC22A6 Q4U2R8 1/20 0.34
SLC22A8 Q8TCC7 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
ESRRG P62508 3/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C19 P33261 2/20 0.33
NPC1 O15118 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
EPHX2 P34913 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7334287 1.00 SOST (0.38) SOSTKDM4EMAPTHIF1ASLC22A6
Trifluoroacetic Acid SCHEMBL7336953 0.90 KAT6A (0.36) SOSTKDM4EMAPTEPHX2POLB
Trifluoroacetic Acid SCHEMBL7334279 0.82 ASIC3 (0.46) SOSTKDM4EMAPTHIF1ASLC22A6
SCHEMBL7335568 0.76 NOS3 (0.48) SOSTKDM4EMAPTHIF1ASLC22A6
Trifluoroacetic Acid SCHEMBL7338135 0.76 PTGS1 (0.48) KMT2AMEN1POLBLMNACA12
Trifluoroacetic Acid SCHEMBL7338119 0.76 PTGS1 (0.48) KMT2AMEN1POLBLMNACA12
Trifluoroacetic Acid SCHEMBL7336945 0.74 ASIC3 (0.46)
Trifluoroacetic Acid SCHEMBL7335899 0.69 PLAU (0.49) KMT2AMEN1ESRRGNPC1RAB9A
Trifluoroacetic Acid SCHEMBL7338600 0.69 PLG (0.42) KDM4EMAPTKMT2AMEN1CYP3A4
Trifluoroacetic Acid SCHEMBL7338612 0.69 PLG (0.42) KDM4EMAPTKMT2AMEN1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010049374-A1 Urokinase inhibitors STEELE ANDREW W (US) 2001-12-06 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed
US-6258822-B1 ENZYME INHIBITORS OF NAPHTHALENE AMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-07-10 US disclosed
EP-1000018-A2 UROKINASE INHIBITORS Abbott Laboratories (US) 2000-05-17 EP disclosed
WO-1999005096-A2 UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 1999-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010049374-A1 Urokinase inhibitors SERPINE1, PLAU, SERPINB1 SOST 1973/4885KDM4E 4285/4885MAPT 3752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.